News and events
PulseOn is chosen as a Top 12 Wearables Techpreneur 2023 in the WT Innovation World Cup®. More than 600 startups, scale-ups, and ground-breaking tech founders and SMEs worldwide submitted their solutions in the Innovation World Cup®. The selected Top 12 companies will present their solutions at the pitch and award ceremony at the 43rd Wearable …
PulseOn’s latest clinical trial article was published in Frontiers in Cardiovascular Medicine on Feb 9, 2023. Wrist-worn device combining PPG and ECG can be reliably used for atrial fibrillation detection in an outpatient setting.(Harri Saarinen et al.) In this article we demonstrated the performance of our wrist-worn solution in detecting atrial fibrillation. The participating doctors …
Frontiers in Cardiovascular Medicine publication Read More »
PulseOn is a top 12 finalist in the 14th Healthcare Innovation World Cup® The 14th Healthcare Innovation World Cup® received around 300 submissions from start-ups, scale-ups, and SMEs worldwide. The Top12 Health Techpreneurs 2022 present their solutions in an exciting pitch final with live jury evaluation. Held at MEDICA, Düsseldorf, on Monday, 14th of November, 13:00 – …
PulseOn will present its innovative arrhythmia detection solution at ESC Congress 2022 in Barcelona, 26 – 29 August 2022.Please visit our stand (J603) for a presentation of the complete system for easy atrial fibrillation detection. See you in Barcelona!
PulseOn attended the 2022 HIMSS European Health Conference & Exhibition bringing the European healthcare community back together in Helsinki, Finland, 14 – 16 June 2022. The PulseOn arrhythmia detection solution was presented to industry innovators at the Startup Village display booth 822. Thank you all the visitors with whom we had great talks, interesting insights …
PulseOn participated at Vitalis, the largest eHealth event in Scandinavia, held in Gothenburg, Sweden, 17 – 19 May 2022. The innovative PulseOn arrhythmia monitor system raised again a lot of interest. Our CEO, Jari Kaija, had a speaker slot to talk about recognizing arrhythmias with the latest technology without interrupting patients normal life. Thank you …
We are pleased to announce that Prof. Dr. Jens Eckstein, CMIO and Head Physician in the University Hospital Basel, has joined the Board of Directors of PulseOn Ltd. Dr Eckstein’s strong experience in electronic patient recording, integration of wearable sensors and patient apps with a focus on atrial fibrillation and stroke prevention will bring significant value to PulseOn.
PulseOn at EHRA 22 in Copenhagen, Denmark, Sunday, 03 April – Tuesday, 05 April 2022 The annual meeting of the European Heart Rhythm Association (EHRA) brought together scientists, healthcare professionals and other players involved in arrhythmia management from all around the world. The newly CE-certified PulseOn arrhythmia detection solution raised a lot of interest. Thank you …
Suomalaisen FinFib-tutkimuksen mukaan vuonna 2018 Suomessa oli 227 000 eteisvärinäpotilasta ja vuosittain uuden diagnoosin saa noin 25 000 suomalaista. Eteisvärinän esiintyvyys kasvaa iän myötä. Hoitamaton eteisvärinä aiheuttaa noin 20 % aivoinfarkteista ja siksi eteisvärinän, erityisesti oireettoman, tunnistus on tärkeää varhaisen verenohennuslääkityksen aloittamiseksi ja aivoverenkiertohäiriöiden ehkäisemiseksi. ”PulseOnin rannelaite ja pilvipalvelu ovat odotettuja työkaluja kardiologille eteisvärinän diagnosointiin. …
PulseOn was invited to the Dutch TV program ´De Barometer´, which showcases the most inventive and original pioneering companies in Europe. PulseOn’s CEO Jari Kaija and medical advisor Cardiologist Kirsi Korpi present PulseOn’s unique Arrhythmia Detection Solution for cardiologists in the Netherlands. See the clip here: https://vimeo.com/647253863
